Telemedicine Strategy to Rescue CPAP Therapy in Sleep Apnea Patients with Low Treatment Adherence: A Pilot Study.
compliance
nasal pressure
obstructive sleep apnea
patient adherence
sleep breathing disorders
telemedicine interventions
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
13 Sep 2021
13 Sep 2021
Historique:
received:
03
08
2021
revised:
10
09
2021
accepted:
10
09
2021
entrez:
28
9
2021
pubmed:
29
9
2021
medline:
29
9
2021
Statut:
epublish
Résumé
Patients with sleep apnea are usually treated with continuous positive airway pressure (CPAP). This therapy is very effective if the patient's adherence is satisfactory. However, although CPAP adherence is usually acceptable during the first months of therapy, it progressively decreases, with a considerable number of patients accepting average treatment duration below the effectiveness threshold (4 h/night). Herein, our aim was to describe and evaluate a novel telemedicine strategy for rescuing CPAP treatment in patients with low adherence after several months/years of treatment. This two-week intervention includes (1) patient support using a smartphone application, phone and voice recorder messages to be answered by a nurse, and (2) daily transmission and analysis of signals from the CPAP device and potential variation of nasal pressure if required. On average, at the end of the intervention, median CPAP adherence considerably increased by 2.17 h/night (from 3.07 to 5.24 h/night). Interestingly, the procedure was able to markedly rescue CPAP adherence: the number of patients with poor adherence (<4 h/night) was considerably reduced from 38 to 7. After one month, adherence improvement was maintained (median 5.09 h/night), and only 13 patients had poor adherence (<4 h/night). This telemedicine intervention (103€ per included patient) is a cost-effective tool for substantially increasing the number of patients with CPAP adherence above the minimum threshold for achieving positive therapeutic effects.
Identifiants
pubmed: 34575234
pii: jcm10184123
doi: 10.3390/jcm10184123
pmc: PMC8470548
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI17/01068
Références
Ann Am Thorac Soc. 2020 Mar;17(3):329-337
pubmed: 31689141
Sleep. 2019 Oct 9;42(10):
pubmed: 31587046
Expert Rev Respir Med. 2017 Sep;11(9):699-709
pubmed: 28621155
Respirology. 2017 Nov;22(8):1508-1517
pubmed: 29024308
Sleep. 2007 Jun;30(6):711-9
pubmed: 17580592
Am J Respir Crit Care Med. 2018 Jan 1;197(1):12-14
pubmed: 28926279
Am J Respir Crit Care Med. 2016 Sep 1;194(5):613-20
pubmed: 26914592
Sleep Breath. 2021 May 15;:
pubmed: 33993394
Lancet Respir Med. 2019 Aug;7(8):687-698
pubmed: 31300334
J Clin Sleep Med. 2021 May 1;17(5):1103-1107
pubmed: 33599202
J Clin Med. 2021 Mar 01;10(5):
pubmed: 33804319
Lancet. 1981 Apr 18;1(8225):862-5
pubmed: 6112294
Chest. 2019 Jun;155(6):1272-1287
pubmed: 30684472
Eur Respir Rev. 2019 Mar 14;28(151):
pubmed: 30872397
Ann Am Thorac Soc. 2020 Mar;17(3):280-281
pubmed: 32108503
ERJ Open Res. 2020 Feb 10;6(1):
pubmed: 32055630
J Telemed Telecare. 2016 Jun;22(4):209-14
pubmed: 26253747
Thorax. 2008 Oct;63(10):860-5
pubmed: 18408048
Am J Respir Crit Care Med. 2010 Apr 1;181(7):718-26
pubmed: 20007932
Am J Respir Crit Care Med. 2018 Jan 1;197(1):117-126
pubmed: 28858567
Eur Heart J. 2012 Sep;33(17):2206-12
pubmed: 22453648
J Med Internet Res. 2020 Feb 18;22(2):e16972
pubmed: 32130137
World J Otorhinolaryngol Head Neck Surg. 2015 Sep 08;1(1):17-27
pubmed: 29204536
JAMA. 2013 Dec 11;310(22):2407-15
pubmed: 24327037
Lancet. 2014 Feb 22;383(9918):736-47
pubmed: 23910433
N Engl J Med. 2016 Sep 8;375(10):919-31
pubmed: 27571048
Cochrane Database Syst Rev. 2020 Apr 7;4:CD007736
pubmed: 32255210
Sleep. 1999 Sep 15;22(6):749-55
pubmed: 10505820
Arch Bronconeumol. 2021 Apr;57:56-58
pubmed: 34629654
Thorax. 2015 Nov;70(11):1054-61
pubmed: 26310452